Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Statement

2 Nov 2017 07:00

RNS Number : 3058V
Elektron Technology PLC
02 November 2017
 

Elektron Technology plc

("Elektron", the "Group" or the "Company")

 

Trading Update

 

Elektron Technology plc (AIM: EKT), the global technology group, is pleased to provide an update on trading for the third quarter ended 31 October 2017.

Sales

Group trading was strong in Q3 with sales increasing 34% compared to the same period last year to £8.6m (2017: £6.4m). Year to date sales have increased by 15% to £22.9m (2017: £19.9m).

Bulgin achieved record quarterly sales of £7.8m in Q3, 37% higher than the same period last year (2017: £5.7m) following successful manufacturing scale-up to convert the unprecedented order demand in H1 into sales. The board expects that Bulgin sales will revert to more normal levels through Q4.

 

Sales £m

Unaudited

Unaudited

Q3 2018

Q3 2017

YTD 2018

YTD 2017

Bulgin

7.8

5.7

20.3

17.4

IMC (Queensgate and Elektron Eye Technology)

0.7

0.7

2.3

2.3

Checkit

0.1

0.3

0.2

 

Total

 

8.6

 

6.4

 

22.9

 

19.9

 

Orders

Group order intake remains well ahead of prior year, with all business segments demonstrating growth.

Bulgin and IMC orders are both 20% above prior year levels year to date.

Checkit has continued to build recurring revenue streams and total contracted annual recurring revenue (including forthcoming contracted installations) now stands at £0.7m, compared with £0.3m at the same time last year (+133%).

Cash

Group net cash was approximately £3.0m at 31 October 2017 (31 July 2017: £2.0m; 31 January 2017: £1.0m) following the initial proceeds from the Sheen Instruments disposal of £1.1m in October. The net cash position has also been impacted by investment in working capital of approximately £0.4m as a result of the strong trading performance in this quarter.

John Wilson, Chief Executive Officer of Elektron, said:

"Q3 trading has been strong. The Board now expects full year performance to be ahead of its previous expectations."

Enquiries:

 

Elektron Technology plc 

www.elektron-technology.com

 

+44 (0) 1223 371 000

John Wilson - Chief Executive Officer

 

Andy Weatherstone - Chief Financial Officer & Company Secretary

 

 

 

finnCap (Nominated Adviser & Broker)

+44 (0)20 7220 0500

Ed Frisby / Scott Mathieson - Corporate Finance

 

Abigail Wayne - Corporate Broking

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

Notes to Editors

Elektron conceives designs and markets innovative engineered products and services for businesses that connect, monitor and control. We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global trends in the following areas:

 

- Demand for ubiquitous power and data: Bulgin

- New waves of "aware" business applications: Checkit

- The effect of ageing on sight: Elektron Eye Technology

- Growth in high precision manufacture: Queensgate

 

Cautionary statement

This financial information has been prepared only for the shareholders of Elektron as a whole and its sole purpose and use is to assist shareholders to exercise their governance rights. Elektron and its Directors and employees are not responsible for any other purpose or use or to any other person in relation to this report.

The report contains indications of likely future developments and other forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. Key risks and their mitigation have not changed materially in the period from those disclosed on pages 12 to 14 of the annual financial statements for the year ended 31 January 2017.

These and other factors could adversely affect the Group's results, strategy and prospects. Forward-looking statements involve risks, uncertainties and assumptions. They relate to events and/or depend on circumstances in the future which could cause actual results and outcomes to differ materially from those currently anticipated. No obligation is assumed to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBUBDBCSGBGRB
Date   Source Headline
29th Jul 20117:01 amRNSAppointment of Chief Financial Officer
29th Jul 20117:00 amRNSResult of AGM and Change of Name
28th Jul 20117:00 amRNSTrading Update
12th Jul 20115:02 pmRNSHolding(s) in Company
30th Jun 20114:58 pmRNSDoc re. Company's Scrip Dividend Scheme
28th Jun 20113:36 pmRNSAnnual Financial Report and Notice of AGM
16th Jun 20111:43 pmRNSHolding(s) in Company
19th May 201110:32 amRNSHolding(s) in Company
16th May 201112:03 pmRNSDirector/PDMR Shareholding
12th May 20117:00 amRNSPreliminary Results
12th Apr 20117:00 amRNSTechnology Update
10th Mar 20117:00 amRNSPre-Close Trading Update
1st Feb 20117:00 amRNSDirector/PDMR Shareholding
31st Jan 201110:24 amRNSDirector/PDMR Shareholding
20th Jan 20119:51 amRNSDirector/PDMR Shareholding and Total Voting Rights
13th Jan 20117:00 amRNSIssue of Equity
17th Dec 20107:00 amRNSTrading Statement
14th Dec 20108:42 amRNSHolding(s) in Company
2nd Dec 20107:00 amRNSHolding(s) in Company
15th Nov 20102:26 pmRNSDirectorate Change
9th Nov 20103:27 pmRNSHolding(s) in Company
5th Nov 20102:24 pmRNSHolding(s) in Company
5th Nov 20107:00 amRNSHolding(s) in Company
4th Nov 20107:00 amRNSDirector/PDMR Shareholding
1st Nov 20104:59 pmRNSHolding(s) in Company
27th Oct 201010:47 amRNSDirector/PDMR Shareholding
27th Oct 201010:47 amRNSDirector/PDMR Shareholding
5th Oct 20103:47 pmRNSDirector/PDMR Shareholding
27th Sep 20102:26 pmRNSDirector/PDMR Shareholding
24th Sep 20107:00 amRNSCompulsory Acquisition Procedure
23rd Sep 20104:32 pmRNSIssue of Equity
17th Sep 20107:00 amRNSIssue of Equity
16th Sep 20104:42 pmRNSHolding(s) in Company
16th Sep 20107:00 amRNSHalf Yearly Report
15th Sep 20101:54 pmRNSDirectorate Change
15th Sep 20107:15 amPRNProposed Cancellation from AIM Close of Offer
15th Sep 20107:00 amRNSOffer Update: Close of Offer
8th Sep 20107:00 amRNSNotification of Interim Results
24th Aug 201011:11 amRNSOffer Document Posted
12th Aug 201012:37 pmRNSDirectorate Change
6th Aug 20102:30 pmRNSDirector/PDMR Shareholding
6th Aug 20102:29 pmRNSHolding(s) in Company
6th Aug 20107:00 amRNSDirectorate Change
6th Aug 20107:00 amRNSHolding(s) in Company
5th Aug 20109:56 amRNSIssue of Equity
2nd Aug 20101:16 pmRNSHolding(s) in Company
30th Jul 20101:00 pmRNSResponse to Offer
30th Jul 20108:45 amRNSForm 8 (OPD) (Hartest Holdings)
30th Jul 20108:37 amRNSOffer for Hartest Holdings
29th Jul 20105:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.